Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ivabradine versus placebo after coronary artery bypass surgery in low cardiac output syndrome
2009-018175-14Phase 2Completed
- Sponsor
- Servier
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of ivabradine in low cardiac output syndrome (LCOS) and coronary arteriosclerosis (2 arms), sponsored by Servier. Primary endpoint: Heart rate responder rate. Started Feb 2010; status: completed.
02
Drugs
ivabradine
03
Conditions
low cardiac output syndrome (LCOS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-018175-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018175-14.